MAFPomalidomide Capsule 1 mg, 2 mg, 3 mg, 4 mg
1) Pomalidomide in combination with bortezomib or cyclophosphamide, plus dexamethasone, for the treatment of patients with relapsed and/or refractory multiple myeloma who have received at least one prior therapy.
2) Pomalidomide in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma who have received at least two prior therapies, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.